Taken together, these findings indicate that although KLK8 inhibition may become an effective strategy against diabetic myopathy, hyperkeratotic skin disease and Alzheimer's disease, it must be used with great caution due to its central nervous system side effects. This evidence concerns the gene KLK8 and early-onset autosomal dominant Alzheimer disease.